End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.064 AUD | -13.51% | -15.79% | +8.47% |
Feb. 28 | Percheron Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
2023 | Dimerix Appoints Nonexecutive Chair | MT |
Sales 2024 * | 3.56M 2.32M | Sales 2025 * | 5.25M 3.43M | Capitalization | 57.7M 37.66M |
---|---|---|---|---|---|
Net income 2024 * | -17M -11.1M | Net income 2025 * | -31M -20.24M | EV / Sales 2024 * | 14.5 x |
Net cash position 2024 * | 6.1M 3.98M | Net cash position 2025 * | 17.41M 11.36M | EV / Sales 2025 * | 7.67 x |
P/E ratio 2024 * |
-3.37
x | P/E ratio 2025 * |
-1.52
x | Employees | 8 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.66% |
1 day | -13.51% | ||
1 week | -15.79% | ||
Current month | -22.89% | ||
1 month | -27.27% | ||
3 months | +12.28% | ||
6 months | +9.40% | ||
Current year | +8.47% |
Managers | Title | Age | Since |
---|---|---|---|
James Garner
CEO | Chief Executive Officer | - | 23-05-07 |
Phillip Hains
DFI | Director of Finance/CFO | 64 | 06-11-08 |
Anthony Filippis
COO | Chief Operating Officer | - | 22-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Phillip Hains
DFI | Director of Finance/CFO | 64 | 06-11-08 |
Ben Price
BRD | Director/Board Member | 68 | 21-10-03 |
James Garner
CEO | Chief Executive Officer | - | 23-05-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.064 | -13.51% | 8,992,853 |
24-04-23 | 0.074 | -2.63% | 885,246 |
24-04-22 | 0.076 | +4.11% | 117,881 |
24-04-19 | 0.073 | -3.95% | 711,375 |
24-04-18 | 0.076 | 0.00% | 322,036 |
End-of-day quote Australian S.E., April 23, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.47% | 37.44M | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.57% | 22.2B | |
-16.53% | 21.23B | |
-8.79% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- PER Stock